UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost‐saving Study

Journal of clinical pharmacy and therapeutics, 2020-10, Vol.45 (5), p.1127-1133

2020

Link zum Volltext

Verfügbarkeit prüfen

Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case-control study in the National COVID Cohort Collaborative (N3C)

BMJ open, 2022-12, Vol.12 (12), p.e066846

2022

Link zum Volltext

Verfügbarkeit prüfen

Evidence of Clinically Meaningful Drug–Drug Interaction With Concomitant Use of Colchicine and Clarithromycin

Drug safety, 2020-07, Vol.43 (7), p.661-668

2020

Link zum Volltext

Verfügbarkeit prüfen

A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)

Drug safety, 2022-08, Vol.45 (8), p.863-871

2022

Link zum Volltext

Verfügbarkeit prüfen

Expanding pharmacists’ roles: Pharmacists’ perspectives on barriers and facilitators to collaborative practice

Journal of the American Pharmacists Association, 2021-03, Vol.61 (2), p.213-220.e1

2021

Link zum Volltext

Verfügbarkeit prüfen

Chronic Gastrointestinal and Joint-Related Sequelae Associated with Common Foodborne Illnesses: A Scoping Review

Foodborne pathogens and disease, 2020-02, Vol.17 (2), p.67

2020

Link zum Volltext

Verfügbarkeit prüfen

Pharmacists’ perceptions of the pharmacists’ patient care process and performance in a simulated patient interaction

Journal of the American Pharmacists Association, 2020-11, Vol.60 (6), p.796-803.e3

2020

Link zum Volltext

Verfügbarkeit prüfen

First-Line Systemic Therapy Outcomes in Western Population with Locally Advanced and Metastatic Gastric Cancer—A Systematic Review

Gastroenterology insights, 2023-11, Vol.14 (4), p.515-537

2023

Link zum Volltext

Verfügbarkeit prüfen

QTc Prolongation with the Use of Hydroxychloroquine and Concomitant Arrhythmogenic Medications: A Retrospective Study Using Electronic Health Records Data

Drugs - Real World Outcomes, 2022-09, Vol.9 (3), p.415-423

2022

Link zum Volltext

Verfügbarkeit prüfen

A Scoping Review of Well-being Assessment and Interventions in Student Pharmacists

American journal of pharmaceutical education, 2022-08, Vol.86 (6), p.8793-758, Article 8793

2022

Link zum Volltext

Verfügbarkeit prüfen

Seroprevalence of Toxoplasma gondii in the U.S.: Evidence from a representative cross-sectional survey

Parasitology international, 2020-12, Vol.79, p.102175-102175, Article 102175

2020

Link zum Volltext

Verfügbarkeit prüfen

Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure

Rheumatology international, 2022-12, Vol.42 (12), p.2253-2259

2022

Link zum Volltext

Verfügbarkeit prüfen

Chimeric antigen receptor T-cell immunotherapies adverse events reported to FAERS database: focus on cytopenias

Leukemia & lymphoma, 2023-12, Vol.64 (13), p.2071-2080

2023

Link zum Volltext

Verfügbarkeit prüfen

Eventos adversos en vacunas COVID-19 en una población de 5 a 17 años: estudio de la base de datos VAERS

Anales de pediatría (Barcelona, Spain : 2003), 2023-04, Vol.98 (4), p.310-312

2023

Link zum Volltext

Verfügbarkeit prüfen

Reply: Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)

The Annals of pharmacotherapy, 2024-02, Vol.58 (2), p.198

2024

Link zum Volltext

Verfügbarkeit prüfen

EVENTOS ADVERSOS EN VACUNAS COVID-19 EN UNA POBLACIÓN DE 5-17 AÑOS, ESTUDIO DE LA BASE DE DATOS VAERS

Anales de pediatría (Barcelona, Spain : 2003), 2022-11

2022

Link zum Volltext

Verfügbarkeit prüfen

Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management

Drug safety, 2023-03, Vol.46 (3), p.223-242

2023

Link zum Volltext

Verfügbarkeit prüfen

Complications Associated with Foodborne Listeriosis: A Scoping Review

Foodborne pathogens and disease, 2022-11, Vol.19 (11), p.725

2022

Link zum Volltext

Verfügbarkeit prüfen

Authors’ Response to Yoshihiro Noguchi’s Comment on: “A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)”

Drug safety, 2022-12, Vol.45 (12), p.1553-1555

2022

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness analysis of five anti-obesity medications from a US payer's perspective

Nutrition, metabolism, and cardiovascular diseases, 2023-06, Vol.33 (6), p.1268-1276

2023

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness analysis of nivolumab-chemotherapy as first-line therapy for locally advanced/metastatic gastric cancer: a United States payer perspective

Expert review of pharmacoeconomics & outcomes research, 2023-08, Vol.ahead-of-print (ahead-of-print), p.1-11

2023

Link zum Volltext

Verfügbarkeit prüfen

Serum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: A systematic review and meta-analysis

American journal of health-system pharmacy, 2021-12, Vol.78 (24), p.2245-2255

2021

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 vaccine adverse events in a population aged 5-17 years: A study from the VAERS database

Anales de pediatría (Barcelona, Spain : 2003), 2023-04, Vol.98 (4), p.310

2023

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 vaccine adverse events in a population aged 5–17 years: a study from the VAERS database

Anales de Pediatría, 2023-04, Vol.98 (4), p.310-312

2023

Link zum Volltext

Verfügbarkeit prüfen

Scoping Review of Toxoplasma Postinfectious Sequelae

Foodborne pathogens and disease, 2021-10, Vol.18 (10), p.687

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Humans
(20)
Pharmacology & Pharmacy
(14)
Drug Interactions
(9)
Medicine
(8)
Medicine & Public Health
(8)
Female
(7)
Male
(7)
Adult
(6)
Middle Aged
(6)
Pharmacology/toxicology
(5)
Adverse Drug Reaction Reporting Systems
(4)
Drug Safety And Pharmacovigilance
(4)
Patients
(4)
Pharmacists
(4)
Public, Environmental & Occupational Health
(4)
Toxicology
(4)
United States - Epidemiology
(4)
Case Reports
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost‐saving Study

Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case-control study in the National COVID Cohort Collaborative (N3C)

Evidence of Clinically Meaningful Drug–Drug Interaction With Concomitant Use of Colchicine and Clarithromycin

A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)

Expanding pharmacists’ roles: Pharmacists’ perspectives on barriers and facilitators to collaborative practice

Chronic Gastrointestinal and Joint-Related Sequelae Associated with Common Foodborne Illnesses: A Scoping Review

Pharmacists’ perceptions of the pharmacists’ patient care process and performance in a simulated patient interaction

First-Line Systemic Therapy Outcomes in Western Population with Locally Advanced and Metastatic Gastric Cancer—A Systematic Review

QTc Prolongation with the Use of Hydroxychloroquine and Concomitant Arrhythmogenic Medications: A Retrospective Study Using Electronic Health Records Data

A Scoping Review of Well-being Assessment and Interventions in Student Pharmacists

Seroprevalence of Toxoplasma gondii in the U.S.: Evidence from a representative cross-sectional survey

Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure

Chimeric antigen receptor T-cell immunotherapies adverse events reported to FAERS database: focus on cytopenias

Eventos adversos en vacunas COVID-19 en una población de 5 a 17 años: estudio de la base de datos VAERS

Reply: Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)

EVENTOS ADVERSOS EN VACUNAS COVID-19 EN UNA POBLACIÓN DE 5-17 AÑOS, ESTUDIO DE LA BASE DE DATOS VAERS

Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management

Complications Associated with Foodborne Listeriosis: A Scoping Review

Authors’ Response to Yoshihiro Noguchi’s Comment on: “A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)”

Cost-effectiveness analysis of five anti-obesity medications from a US payer's perspective

Cost-effectiveness analysis of nivolumab-chemotherapy as first-line therapy for locally advanced/metastatic gastric cancer: a United States payer perspective

Serum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: A systematic review and meta-analysis

COVID-19 vaccine adverse events in a population aged 5-17 years: A study from the VAERS database

COVID-19 vaccine adverse events in a population aged 5–17 years: a study from the VAERS database

Scoping Review of Toxoplasma Postinfectious Sequelae

Suchergebnisse filtern